Description
Elsevier - Health Sciences Division HER2-Positive Breast Cancer 1e by Sara Hurvitz Kelly McCann
Get a quick expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2 which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz and Kelly McCann consolidates todays available information on this growing topic into one convenient resource making it an ideal easy-to-digest reference for practicing and trainee oncologists.Covers the diagnosis treatments and targeted therapies and management of breast cancers that are HER2-positive.Contains sections on background and testing advanced disease therapeutics and toxicity considerations.Includes a timely section on innovative future therapies.show more